Upper Limb Spasticity
📧 Sign up to get email alerts when something new happens for Upper Limb Spasticity.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity. [Phase 1, Phase 2]
Ipsen is conducting a Phase 1/2 study to evaluate IPN10200 for upper limb spasticity in adults, and the trial is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: A Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in Multiple Treatments of Adult Upper Limb Spasticity [Phase 3]
A Phase 3 clinical trial evaluating recombinant botulinum toxin type A (YY001) for injections to treat upper limb spasticity in adults is cu…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: CARegiver BURden, Effectiveness and Other Health Care Measures on Functional Disability, in Patients Treated With Abobotulinumtoxin A for Upper Limb Spasticity
This clinical trial update describes caregiver burden, effectiveness, and other health care outcomes in patients with upper limb spasticity …
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: A Clinical Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in The Treatment of Upper Limb Spasticity in Adults [Phase 2, Phase 3]
A Phase 2/3 study of recombinant botulinum toxin type A (YY001) for treating upper limb spasticity in adults is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection in the Treatment of Adult Upper Limb Spasticity . [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of recombinant botulinum toxin type A (Eveotox) injected for adults with upper lim…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: A Single Centre, Prospective, Observational Study to Assess the Use of the Rehabilitation Tool, GripAble, in Patients With Upper Limb Spasticity Receiving Botulinum Toxin-A (BoNT-A) in the United Kingdom (UK).
This completed prospective observational study evaluated the use of the GripAble rehabilitation tool in patients with upper limb spasticity …